UNDERWRITING AGREEMENT among GLAXOSMITHKLINE CAPITAL PLC as Issuer GLAXOSMITHKLINE PLC as Guarantor and as Representatives of the Underwriters Dated as of [ ], 20[ ]Underwriting Agreement • March 21st, 2014 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 21st, 2014 Company Industry JurisdictionNote: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.
ContractIndenture • March 21st, 2014 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 21st, 2014 Company Industry JurisdictionSECOND SUPPLEMENTAL INDENTURE dated as of March 21, 2014, among GlaxoSmithKline Capital Inc., a corporation organized under the laws of the State of Delaware (the “Company”), GlaxoSmithKline plc, a public limited company incorporated under the laws of England and Wales, as guarantor (the “Guarantor”), and Law Debenture Trust Company of New York (as successor to Citibank, N.A.), a company duly organized and existing under the laws of the State of New York (the “Trustee”).
ContractFirst Supplemental Indenture • March 21st, 2014 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 21st, 2014 Company Industry JurisdictionFIRST SUPPLEMENTAL INDENTURE dated as of March 21, 2014, among GlaxoSmithKline Capital plc, a public limited company incorporated under the laws of England and Wales (the “Company”), GlaxoSmithKline plc, a public limited company incorporated under the laws of England and Wales, as guarantor (the “Guarantor”), and Law Debenture Trust Company of New York (as successor to Citibank, N.A.), a company duly organized and existing under the laws of the State of New York (the “Trustee”).
ContractFirst Supplemental Indenture • March 21st, 2014 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 21st, 2014 Company Industry JurisdictionFIRST SUPPLEMENTAL INDENTURE dated as of March 21, 2014, between GlaxoSmithKline plc, a public limited company incorporated under the laws of England and Wales (the “Company”) and Law Debenture Trust Company of New York, a company duly organized and existing under the laws of the State of New York (the “Trustee”).